Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Countries with the Highest Rates of Lung Cancer

In this article, we take a look at the 15 countries with the highest rates of lung cancer. If you would like to skip our detailed analysis of the lung cancer therapeutics industry, you can directly go to the 5 Countries with the Highest Rates of Lung Cancer.

Lung cancer is the second most common type of cancer in the world. Statistics worldwide showcase that the prevalance of the disease has increased globally over the past few years. This escalation in the number of individuals with lung cancer has led to a growing demand for advanced technology to deal with the illness and its side effects. As a result of this trend, the lung cancer therapeutics market has been witnessing steady growth all around the globe. According to Precedence Research, the global lung cancer therapeutics market was valued at $28 billion in 2022 and is expected to be worth more than $59.61 billion by 2032. The predicted CAGR for the period 2023-2032 is currently 7.90%, meaning that the industry is only anticipated to do well. 

If we take a region-wise approach, North America currently dominates the market and is expected to do so throughout the forecast period. The two main reasons for this market size are the increased penetration of health insurance and a significantly developed healthcare infrastructure. Furthermore, many leading biopharmaceutical companies are also present in this region, contributing immensely to the growth of the North American lung cancer market. You can also check out the 14 Best Cancer Stocks To Buy Now in order to get more insight on this topic. 

Bristol-Myers Squibb Co (NYSE:BMY) is one of the leading companies when it comes to cancer research in the US. The company has conducted detailed research trials on how lung cancer can be dealt with during the earlier stages of the disease before it spreads. As recently as September 2023, Bristol-Myers Squibb Co (NYSE:BMY) announced favorable results pertaining to a therapy method they were testing for non-small cell lung cancer. NSCLC is currently one of the most common types of lung cancer, and it can represent up to 84% of all diagnoses. Bristol-Myers Squibb Co (NYSE:BMY) has also been carrying out many other cancer-related trials side by side, some of which have received approval from the EU. 

Some of the latest research on lung cancer has shown that low-dose CT scans can help screen for lung cancer in those who smoke heavily. This is particularly helpful because lung cancer is more likely to be treated successfully if caught at earlier stages. Furthermore, the CDC reports that 80% to 90% of lung cancer-related deaths in the US are linked to tobacco smoking, making this the leading cause of the disease in the country. The issue’s prevalence can be estimated from the fact that the size of the US tobacco industry, as estimated by Grand View Research, is $75.9 billion as of 2021, with the country being the world’s 9th largest tobacco exporter. So not only is tobacco production a national issue, but the industry has also expanded its operations beyond borders. You can check out the 12 Countries that Export the Most Tobacco to see the world’s leading contributors in the tobacco export industry. 

Within the US tobacco market, Philip Morris International Inc. (NYSE:PM) is the biggest tobacco seller, reporting a sale of 622 billion units in the year 2022. However, it is pertinent to note that according to various studies, overall tobacco usage has been facing a steady decline for at least the past two decades. Specifically from 2020 to 2021, tobacco sales in the US fell 6.7%, a trend which also affects companies like Philip Morris International Inc. (NYSE:PM). Philip Morris International Inc. (NYSE:PM) itself has revealed that its shipment volumes for tobacco have decreased because the company is committed to delivering a smoke-free future. The downward trend in tobacco sales can be attributed to many reasons, such as stringent laws, heavy taxation, and powerful mass media campaigns. 

Countries with the Lowest Lung Cancer Rates

There are several countries whose lung cancer rates are among the lowest in the world. These include countries like Yemen, Oman, Pakistan and Sri Lanka, among others. For example, Pakistan’s age-standardized incidence rate for lung cancer is only 6 per 100,000 individuals. Contrary to what most believe, lung cancer statistics show that lung cancer rates are higher in Europe than in Asia.

Is Vaping a Healthy Alternative to Traditional Tobacco Smoking?

Big tobacco companies have now shifted their focus towards vapes or products with heated tobacco, generally marketing them as ‘safer’ alternatives to cigarette smoking. However, the latest studies on the subject have found that these products can be as harmful as cigarettes, contributing to several kinds of respiratory diseases. Thus, even places where vaping is more common than cigarette smoking can sometimes find their place in the list of the countries with the highest rates of lung cancer. We have compiled this ranking of the top 15 places with the most lung cancer cases by viewing lung cancer statistics by country and age. 

A healthcare professional examining T-cell immunotherapy. Editorial photo for a financial news article. 8k. –ar 16:9

Our Methodology

For the purpose of this list of countries with the highest rates of lung cancer, we have referred to data compiled by the International Agency for Research on Cancer, an organization that works under the WHO. The data is retrieved from Cancer Today, which provides various data visualization tools for understanding the prevalence and incidence of multiple types of cancers globally. The data is acquired through a collaboration between the WHO and various population-based cancer registries throughout the world or the International Association of Cancer Registries.

Based on this methodology, the following are the 15 countries with the highest rates of lung cancer depending on the incidence rates for an age-standardized range of 10-69 years for both sexes: 

15. North Korea 

Value: 31.6 

Lung cancer is the leading cause of cancer-related deaths in North Korea, especially in the female population. Air pollution and second-hand smoke are believed to be two major causes of lung cancer in the country, causing many non-smokers to develop cancer as well. North Korea also has a significant amount of disparities in access to healthcare, making adequate treatment challenging to come by. Data is also scarce, which makes it harder to derive essential healthcare-related conclusions. 

14. Denmark

Value: 32.1 

Denmark has been referred to by some as the ‘cancer capital’ of the world owing to the high prevalence of various types of cancer in the country. Tobacco smoking is the biggest reason Denmark is considered one of the countries with the highest lung cancer rates, so much so that lung cancer within the country has placed a significant economic burden on the population. Individuals diagnosed with lung cancer not only bear higher healthcare costs but also face an indirect burden in terms of reduced household income. 

13. Romania

Value: 32.9

Lung cancer is the biggest culprit behind cancer-related deaths in Romania as well, while also being the leading cancer diagnosis among men. Lung cancer rates in the country are at an all-time, which is the recipe for disaster when paired with limited access to healthcare. These circumstances have led to recent studies that ask for a comprehensive lung cancer registry within the country so the healthcare system can be better prepared for rising lung cancer rates. Romania is also among the European countries with the highest cancer mortality rates. 

12. Poland 

Value: 33.4

Both active and passive smoking are two of the biggest causes behind Poland being one of the countries with the highest rates of lung cancer. Hence, we see a consistent trend between almost all the countries on this list when it comes to the risk factors behind lung cancer. Air pollution is another pertinent problem in the country that leads to lung cancer. Due to Poland’s heavy dependence on coal for power generation, 36 out of the 50 most polluted EU cities are in Poland. This forms quite an unsettling basis for increasing cases of not just cancer but various other diseases. 

11. Croatia 

Value: 33.7

Croatia is another country that ranks amongst the European countries with the highest rates of cancer mortality, often finding its place in the top three. Croatia ranks relatively high in prevalence of various tobacco-related cancers, meaning that any strategy to combat the diseases would have to come with a significant level of tobacco control. Croatia was a transitional European state for many years, only recently achieving the ‘developed’ status. Due to the transition, access to healthcare and research has improved, but there are still many factors to combat to provide better access to anticancer treatments. 

10. North Macedonia 

Value: 34.6

The lung cancer rate in North Macedonia has seen a steady increase over the past few years, with almost 80% of the patients being men and 9 out of 10 patients being smokers. In 2019, North Macedonia had one of the world’s biggest populations of smokers, with almost 46% of its adults smoking some form of tobacco. Smoking cessation treatment programs in the country are also quite limited, making this one of the countries with the highest lung cancer rates.  

09. New Caledonia

Value: 34.6

While tobacco is one of the most common causes of lung cancer across this list, studies conducted in New Caledonia have also pinpointed certain occupational exposures as a reason behind high lung cancer rates. People exposed to elements like field dust or asbestos were usually the ones who struggled with this kind of lung cancer. Thus, New Caledonia is a prime example of the fact that controlling tobacco usage should not be the only policy to deal with lung cancer. 

08. France

Value: 34.9

Despite comprehensive tobacco control policies and a decreasing population of smokers, France still has one of the highest consumptions of tobacco in the Western world. France is also the EU state with the most number of vapers, making the country A-list in the consumption of two huge cancer-causing products. The good part is the country generally has a sound healthcare system, with 12 out of its 18 cancer centers being ranked in the world’s best oncology hospitals, two of them in the top 50. However, there are still disparities in access when it comes specifically to lung cancer, making France one of the countries with the highest rates of lung cancer. 

07. Belgium

Value: 35.4 

Lung cancer is the second most common type of cancer in Belgium but has the highest mortality rates. One of the biggest reasons is the late onset of symptoms, due to which, many people get diagnosed after the cancer has already metastasized. Similar to other countries with the highest rates of lung cancer, the increasing number of diagnoses in Belgium has also been linked to an increase in the population of smokers, especially females

06. Turkey 

Value: 35.8

Every year, more than 27,000 people are diagnosed with lung cancer in Turkey. Like other developed countries, Turkey has also been facing a steady increase in cancer patients. In addition to socioeconomic factors, an aging population is also a big reason behind the high incidence of cancer. As Turkey’s young population ages in the coming years, some experts predict this will become a massive problem in terms of managing diseases like cancer.

Click to continue reading and see the 5 Countries with the Highest Rates of Lung Cancer.

Suggested Articles:

Disclosure: None. 15 Countries with the Highest Rates of Lung Cancer is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…